FDA Import Refusal AEK-5241265-5/11/1 — NOVO NORDISC PHARMA GMH
The FDA refused shipment AEK-5241265-5/11/1 from NOVO NORDISC PHARMA GMH (Germany) on Jun 25, 2024. The refused product falls under Drugs and Biologics — SEMAGLUTIDE (ANTI-DIABETIC). Cited charge: 118 This firm has 1 other import refusal on record.
Refusal details
- Date
- Jun 25, 2024
- Country
- Germany
- Product Category
- Drugs and Biologics
- Product Code
- 61PAY72 SEMAGLUTIDE (ANTI-DIABETIC)
- Charges
- 118